News | October 02, 2013

October 2, 2013 — Proton therapy is the most advanced radiation technique available. Unfortunately, access to proton therapy is limited due to the low number of proton therapy centers. Research institutes and hospitals are now frequently investing in proton therapy to make it more accessible to patients.

According to the "US Proton Therapy Outlook 2017" by RNCOS, the United States will be home to almost 27 proton therapy centers by 2017, almost double the current figure, and attain revenue of $1.17 billion. The 65-page report provides an insight into the demographics and historical trend (2008-2013) of cancer incidences, deaths and prevalence along with statewide and site-wide cancer incidences in the United States.

The study dedicates a complete chapter on the various components of any proton therapy center and covers issues related to accelerators, delivery, transportation, planning and positioning systems to human resources required to setup a center.

The report further provides the statewide statistics of potential patients for proton therapy and the latter's current market penetration. It also includes a section dedicated to market opportunity assessment, which would help service providers and vendors to extract benefits from the largely untapped but lucrative market.

After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges that will have a major influence on shaping the growing market. On the competitive front, the report covers the current stand and its probable transformation by 2017 for service providers and equipment vendors. Additionally, the report provides analyses of equipment vendors as well as their business overviews, products and services and existing and planned installations in the United States until 2017.

For more information: www.rncos.com


Related Content

News | ASTRO

October 6, 2022 ‑— Ahead of the 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO), set for ...

Time October 06, 2022
arrow
News | ASTRO

The 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO) will take place October 23-26, at the ...

Time September 29, 2022
arrow
News | Radiation Oncology

September 26, 2022 — Cleveland Clinic received a $7.9 million five-year grant from the National Cancer Institute at the ...

Time September 26, 2022
arrow
News | Treatment Planning

September 12, 2022 — Sunnybrook Health Sciences Centre, one of Canada’s largest hospitals, offers a highly specialized ...

Time September 12, 2022
arrow
News | Prostate Cancer

September 8, 2022 — In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with ...

Time September 08, 2022
arrow
News | Radiology Business

September 7, 2022 — Accuray Incorporated announced the company is joining forces with Genolier Innovation Hub, a fully ...

Time September 07, 2022
arrow
News | PET Imaging

August 30, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT), a ...

Time August 30, 2022
arrow
News | Radiopharmaceuticals and Tracers

August 26, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time August 25, 2022
arrow
News | Radiation Therapy

August 23, 2022 — Elekta announced that it has received CE mark for its Elekta Esprit, a new Leksell Gamma Knife ...

Time August 23, 2022
arrow
News | Prostate Cancer

August 16, 2022 — A new study published by University of Kentucky Markey Cancer Center researchers suggests that the ...

Time August 16, 2022
arrow
Subscribe Now